Cardiac MRI in Fabry disease
- PMID: 36818911
- PMCID: PMC9931723
- DOI: 10.3389/fcvm.2022.1075639
Cardiac MRI in Fabry disease
Abstract
Fabry disease is a rare, progressive X-linked inherited disorder of glycosphingolipid metabolism due to a deficiency of α-galactosidase A enzyme. It leads to the accumulation of globotriaosylceramide within lysosomes of multiple organs, predominantly the vascular, renal, cardiac, and nervous systems. Fabry cardiomyopathy is characterized by increased left ventricular wall thickness/mass, functional abnormalities, valvular heart disease, arrhythmias, and heart failure. Early diagnosis and treatment are critical to avoid cardiac or renal complications that can significantly reduce life expectancy in untreated FD. This review will focus on the role of cardiovascular magnetic resonance imaging in the diagnosis, clinical decision-making, and monitoring of treatment efficacy.
Keywords: Fabry disease; cardiomyopathy; feature tracking; left ventricular hypertrophy; magnetic resonance imaging; myocardial mapping.
Copyright © 2023 Umer and Kalra.
Conflict of interest statement
The authors declare that the review was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
2024 Update of the TSOC Expert Consensus of Fabry Disease.Acta Cardiol Sin. 2024 Sep;40(5):544-568. doi: 10.6515/ACS.202409_40(5).20240731A. Acta Cardiol Sin. 2024. PMID: 39308653 Free PMC article.
-
Cardiac Involvement in Fabry Disease and the Role of Multimodality Imaging in Diagnosis and Disease Monitoring.Curr Probl Cardiol. 2023 Jan;48(1):101439. doi: 10.1016/j.cpcardiol.2022.101439. Epub 2022 Oct 4. Curr Probl Cardiol. 2023. PMID: 36202174 Review.
-
Treatment of Fabry Disease: Established and Emerging Therapies.Pharmaceuticals (Basel). 2023 Feb 20;16(2):320. doi: 10.3390/ph16020320. Pharmaceuticals (Basel). 2023. PMID: 37259462 Free PMC article. Review.
-
Cardiac magnetic resonance in Fabry disease.Eur Heart J Suppl. 2023 Apr 26;25(Suppl C):C200-C204. doi: 10.1093/eurheartjsupp/suad045. eCollection 2023 May. Eur Heart J Suppl. 2023. PMID: 37125302 Free PMC article.
-
Anderson-Fabry disease: a multiorgan disease.Curr Pharm Des. 2013;19(33):5974-96. doi: 10.2174/13816128113199990352. Curr Pharm Des. 2013. PMID: 23448451 Review.
Cited by
-
Cardiac magnetic resonance imaging in Fabry disease.J Clin Imaging Sci. 2025 Jun 25;15:23. doi: 10.25259/JCIS_155_2024. eCollection 2025. J Clin Imaging Sci. 2025. PMID: 40709293 Free PMC article.
-
2024 Update of the TSOC Expert Consensus of Fabry Disease.Acta Cardiol Sin. 2024 Sep;40(5):544-568. doi: 10.6515/ACS.202409_40(5).20240731A. Acta Cardiol Sin. 2024. PMID: 39308653 Free PMC article.
-
Fabry Disease: Insights into Pathophysiology and Novel Therapeutic Strategies.Biomedicines. 2025 Mar 4;13(3):624. doi: 10.3390/biomedicines13030624. Biomedicines. 2025. PMID: 40149601 Free PMC article. Review.
-
Amyloid and Anderson-Fabry disease: Can there be a CMR phenotypic overlap?J Cardiol Cases. 2025 Jan 16;31(4):109-112. doi: 10.1016/j.jccase.2024.12.005. eCollection 2025 Apr. J Cardiol Cases. 2025. PMID: 40469430 Free PMC article.
-
Effects of switching from agalsidase-α to agalsidase-β on biomarkers, renal and cardiac parameters, and disease severity in fabry disease forming neutralizing antidrug antibodies: a case report.CEN Case Rep. 2024 Aug;13(4):290-296. doi: 10.1007/s13730-023-00843-1. Epub 2023 Dec 22. CEN Case Rep. 2024. PMID: 38135868 Free PMC article.
References
-
- Umer M, Motwani M, Jefferies J, Nagueh S, Kalra D. Cardiac involvement in Fabry disease and the role of multimodality imaging in diagnosis and disease monitoring. Curr Probl Cardiol. (2023) 48:101439. - PubMed
Publication types
LinkOut - more resources
Full Text Sources